Daniel Henry

daniel-henryDaniel Henry (64 years old), is an experienced senior executive and management consultant with a broad international background and more than 30 years of top level management experience in the healthcare industry. He was with Merck KgaA for 29 years and for 16 of those years he was CFO and Managing Director of Merck France. In his role as Managing Director he was responsible for business units with €1.13 billion in sales and 4,200 employees. During his time working for Merck in France he completed 11 acquisitions.

Latterly Daniel has had considerable success as a consultant or business "coach" to several small and medium size companies in diverse industries where he has advised on finance, corporate strategy and development, mergers and acquisitions, strategic sourcing and management of information systems. He has a Masters Degree in accountancy from Reims University and an Executive MBA from HEC Paris (École des Hautes Études Commerciales, France). He is a partner and co-founder of Covivium, a corporate finance consultancy. Daniel is currently non-executive Chairman at Phynova (www.phynova.com) and Chairman of the supervisory board at Ago Pharma (holding company, Paris).



    Multi-drug-resistant tuberculosis

    South Africa recorded 12,000 cases of Multi-drug-resistant tuberculosis (MDR-TB) per year (out of a total of 400,000 infections). To try to stop this "major public health problem", the country is testing a new antibiotic, Bedaquiline (Sirturo).


    Antibiotic and epilepsy

    Scientists from Great Ormond Street Hospital in London (UK) warned against erythromycin, an antibiotic prescribed against urinary or respiratory infections. In pregnant women, it would promote infant epilepsy.


    US balance

    Bacterial resistance caused 23,000 deaths and 2 million infections per year in the United States. To fight, Washington wants to cut "50% of the inappropriate use of antibiotics in ambulatory care" and "20% in hospitals."


    American Plan

    By 2020, the US wants a 60% reduction of nosocomial infections resistant Enterobacteriaceae, 50% C difficile infections and septicemia S aureus methicillin and 35% pseudomonas infections (see document).


    Food and bacteria

    According to the World Health Organization (WHO), foods containing bacteria, viruses, parasites or chemicals are responsible for more than 200 diseases (diarrhea, cancers) causing 2 million deaths per year.


    Tobacco and bacteria

    According to a study published in the journal Infection and Immunity by researchers at the University of California, cigarette smoke increases the resistance of bacteria such as Staphylococcus Aureus methicillin-resistant (SAMR).


    First lethal cause in 2050

    The O'Neill report on antimicrobial resistance & its consequences (dec. 2014) show that it would become the first lethal cause in the world in 2050 if nothing's changed by then. Source : O'Neill report. report.


    WHO plan

    The World Health Organization (WHO) has indicated that it will present in May a plan of action to fight against the misuse of antibiotics. Source : WHO



    Domestic bacteria

    Researchers at the University of Raleigh, North Carolina (USA) identified the microbial fauna in 1,430 apartments in North America. Result: 75,000 genetic markers of different bacteria and 35,000 different types of mushrooms. Source: New Scientist



    October 11-14, 2015


    Symposium : New Approaches and Concepts in Microbiology


    Heidelberg, Germany


    December 15-18, 2015


    2nd International Conference on Infectious Diseases and Nanomedicine


    Kathmandu, Nepal